Skip to content

Iran Anti-Rheumatic Drug Market Evaluation Report 2022: A $2+ Billion Market by 2027 That includes GlaxoSmithKline, F. Hoffmann-La Roche, & Novartis –

DUBLIN–(BUSINESS WIRE)–The “Iran Anti-Rheumatic Drug Market – Forecasts from 2022 to 2027” report has been added to’s providing.

Iran’s antirheumatic medication market was evaluated at US$1,645.313 million within the 12 months 2020, rising at a CAGR of three.16% reaching the market measurement of US$2,045.699 million by the 12 months 2027.

Heat, swollen, & painful joints are signs of the medical sickness rheumatoid arthritis. The sickness primarily impacts an individual’s fingers and wrists. Ache is a symptom of this medical illness, and it will get worse over time. Totally different drugs, known as anti-rheumatics, are used to deal with this sickness.

Moreover, these drugs are used to change the course of the sickness. As an example, anti-rheumatic drugs that scale back the development of the illness embody disease-modifying anti-rheumatics medication. Moreover, drugs akin to non-steroidal anti-inflammatory medicines are used to deal with rheumatoid arthritis.

The marketplace for antirheumatic medication in Iran is projected to develop on account of the excessive prevalence of rheumatoid arthritis within the nation, together with the presence of a significantly excessive proportion of the geriatric inhabitants within the nation. Moreover, the rising incidence of cardiovascular ailments within the nation can be anticipated to be one of many key components supplementing the market progress within the nation throughout the subsequent 5 years.

Additionally, the burden of CVD will improve by greater than double the speed in 2005 by 2025. Moreover, the excessive variety of circumstances within the nation with energetic malaria foci can be anticipated to bolster the demand for antirheumatic medication, thereby positively impacting the market progress throughout the subsequent 5 years. As an example, in accordance with a report from the World Well being Group, the variety of individuals dwelling with energetic foci was greater than 340,000 in 2017.

Moreover, the rising participation of home pharmaceutical corporations within the type of rising investments in pharma R&D for the event of quite a few high-cost medication domestically to faucet the potential of the market that it holds additionally widens up the alternatives for the market to develop throughout the subsequent 5 years.

Iran’s antirheumatic medication market has been segmented based mostly on the kind of illness, sort of molecule, and gross sales channel. By sort of illness, the market has been segmented as osteoarthritis, rheumatoid arthritis, gout, lupus, and others. By sort of molecule, the Iranian antirheumatic medication market has been labeled into prescribed drugs and biopharmaceuticals. The market segmentation has additionally been carried out by gross sales channel as prescription and over-the-counter (OTC).

The rheumatoid arthritis sector is predicted to carry a big market share relying on the kind of illness. The trade for rheumatoid arthritis therapy is fueled by the rising prevalence of arthritis and related joint points. As well as, the event of rheumatoid arthritis is attributed to a change in direction of an unhealthy way of life, a rise in metabolic ailments and age, a household historical past of joint issues, and a rise in weight problems. Moreover, enhancements in biosimilar and progressive biologics are anticipated to open up new enterprise prospects within the sector.

As a result of rise within the variety of specialist hospitals wanted to deal with the medical situation, the prescription-based drug section held the largest share of the market by gross sales channel. Moreover, on account of elevated consciousness of the rheumatoid arthritis therapy decisions, the over-the-counter drugs sector is anticipated to develop on the quickest charge throughout the projection interval. One other vital factor driving the growth of the anti-rheumatics enterprise is the easy accessibility of over-the-counter NSAIDs.

Key Subjects Lined:


2.Analysis Methodology

2.1. analysis information

2.2. assumptions

3.Government Abstract

3.1. Analysis Highlights

4.Market Dynamics

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s 5 Forces Evaluation

4.4. Business Worth Chain Evaluation

5. Iran Antirheumatic Drug Market Evaluation, By Sort of Illness

5.1. Introduction

5.2. osteoarthritis

5.3. Rheumatoid Arthritis

5.4. gout

5.5. Lupus

5.6. others

6. Iran Antirheumatic Drug Market Evaluation, By Sort of Molecule

6.1. Introduction

6.2. Prescribed drugs

6.3. Biopharmaceuticals

7. Iran Antirheumatic Drug Market Evaluation, By Gross sales Channel

7.1. Introduction

7.2. prescription

7.3. Over-The-Counter (OTC)

8. Aggressive Atmosphere and Evaluation

8.1. Main Gamers and Technique Evaluation

8.2. Rising Gamers and Market Lucrativeness

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix

9.Firm Profiles

9.1. GlaxoSmithKline plc

9.2. F. Hoffmann-La Roche Ltd

9.3. Novartis

For extra details about this report go to is the world’s main supply for worldwide market analysis stories and market information. We give you the most recent information on worldwide and regional markets, key industries, the highest corporations, new merchandise and the most recent developments.

Leave a Reply

Your email address will not be published. Required fields are marked *